Firmenbeschreibung
Illumina, Inc. ist ein US-amerikanisches Unternehmen, das im Bereich Genforschung tätig ist. Die Kernkompetenzen des Konzerns liegen auf der Entwicklung, Herstellung und Vermarktung von Life Science-Geräten und integrierten Systemen für die Analyse von genetischen Variationen und Funktionen. In diesem Zusammenhang werden innovative Sequenzierungs- und Array-basierte Lösungen für Genotypisierung, Variationsanalyse, Methylierung sowie Genprofilierung und DNA-, RNA- und Protein-Untersuchung in Studien zur Verfügung gestellt. Darüber hinaus enthält das Leistungsspektrum auch Services und Hilfsmittel im Bereich Genomik und Diagnostik. Dabei kommen die Lösungen und Produkte der Gesellschaft in vielfältigen Bereichen wie beispielsweise bei Pharma- und Biotechnologieunternehmen wie auch bei Regierungs- und Bildungsbehörden weltweit zum Einsatz. Im Wesentlichen dienen die Produkte und Technologien von Illumina der Erforschung von Genmaterial sowie einer schnellen Analyse und ebnen den Weg für molekulare Medizin. Nicht zuletzt werden durch DNA- und Protein-Analysen Fortschritte in der Erforschung von Krankheiten, Medikamenten und molekularen klinischen Tests ermöglicht.
KeyData
| endOfFinancialYear: | 31.12.2024 00:00 |
| stockholderStructure: | Vanguard Group (11.4115%),BlackRock Inc. (8.35091%),EDGEWOOD MANAGEMENT LLC (4.31795%),State Street Corporation (4.22073%),BAILLIE GIFFORD CO (3.31184%),LOOMIS SAYLES CO L P (2.77758%),HENDERSON GROUP PLC (2.76358%),Morgan Stanley (2.32155%),GEODE CAPITAL MANAGEMENT LLC (2.28134%),Wellington Management Group (2.03328%) |
| sharesOutstanding: | 158600000.0000 |
| ceo: | Jacob Thaysen, PhD |
| board: | Ankur Dhingra, Steve Barnard, PhD, Nicole Berry, Todd Christian, Everett Cunningham, Scott Davies, Pat Leckman, Kevin Pegels, Carissa Rollins, Salli Schwartz, Bas Verhoef, Jakob Wedel, Gretchen Weightman, Jenny Zheng |
| supervisoryBoard: | Stephen P. MacMillan, Jacob Thaysen, PhD, Frances Arnold, PhD, Caroline Dorsa, Robert S. Epstein, Scott Gottlieb, Gary S. Guthart, Anna Richo, Philip Schiller, Sue Siegel, Scott B. Ullem |
| countryID: | 20 |
| freeFloat: | 48.2900 |
| faceValue: | 0.0100 |
| faceValueCurrencyID: | 4 |
| faceValueCurrency: | USD |
| sectorName: | Medizintechnische Produkte |
| industryName: | Gesundheitswesen |
| subsectorName: | Hochentwickelte medizinische Geräte |
| country: | USA |
| countryName: | USA |
Kontakt
| phone: | +1-858-291-6421 |
| email: | ir@illumina.com |
| irWebSite: | https://investor.illumina.com/investors/default.aspx |
Adresse
| street: | 5200 Illumina Way |
| city: | San Diego, California 92122, USA |
| phone: | +1-858-202-4500 |
| fax: | +1-858-202-4766 |
| webSite: | www.illumina.com/ |
| email: | info@illumina.com |
Finanzen (kurz)
| year: | 2021 | cash: | 1232.0000 |
| balanceSheetTotal: | 15217.0000 | liabilities: | 4477.0000 |
| shareCapital: | 2.0000 | totalShareholdersEquity: | 10740.0000 |
| sales: | 4526.0000 | bankLoans: | -123.0000 |
| investment: | 0.0000 | incomeBeforeTaxes: | 884.0000 |
| netIncome: | 762.0000 | cashFlow: | -578.0000 |
| employees: | 9100 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
| year: | 2022 | cash: | 2011.0000 |
| balanceSheetTotal: | 12252.0000 | liabilities: | 5653.0000 |
| shareCapital: | 2.0000 | totalShareholdersEquity: | 6599.0000 |
| sales: | 4584.0000 | incomeBeforeTaxes: | -4336.0000 |
| netIncome: | -4404.0000 | cashFlow: | 779.0000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2023 | cash: | 1048.0000 |
| balanceSheetTotal: | 10111.0000 | liabilities: | 4366.0000 |
| shareCapital: | 2.0000 | totalShareholdersEquity: | 5745.0000 |
| sales: | 4504.0000 | incomeBeforeTaxes: | -1117.0000 |
| netIncome: | -1161.0000 | cashFlow: | -963.0000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
Finanzen (kurz)
| year: | 2021 |
| cash: | 1232.0000 |
| balanceSheetTotal: | 15217.0000 |
| liabilities: | 4477.0000 |
| shareCapital: | 2.0000 |
| totalShareholdersEquity: | 10740.0000 |
| sales: | 4526.0000 |
| bankLoans: | -123.0000 |
| investment: | 0.0000 |
| incomeBeforeTaxes: | 884.0000 |
| netIncome: | 762.0000 |
| cashFlow: | -578.0000 |
| employees: | 9100 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2022 |
| cash: | 2011.0000 |
| balanceSheetTotal: | 12252.0000 |
| liabilities: | 5653.0000 |
| shareCapital: | 2.0000 |
| totalShareholdersEquity: | 6599.0000 |
| sales: | 4584.0000 |
| incomeBeforeTaxes: | -4336.0000 |
| netIncome: | -4404.0000 |
| cashFlow: | 779.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2023 |
| cash: | 1048.0000 |
| balanceSheetTotal: | 10111.0000 |
| liabilities: | 4366.0000 |
| shareCapital: | 2.0000 |
| totalShareholdersEquity: | 5745.0000 |
| sales: | 4504.0000 |
| incomeBeforeTaxes: | -1117.0000 |
| netIncome: | -1161.0000 |
| cashFlow: | -963.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2022 | units: | 1000000 |
| balanceSheetTotal: | 12252.0000 | cash: | 2011.0000 |
| currentAssets: | 3561.0000 | fixedAssets: | 8691.0000 |
| liabilities: | 2773.0000 | totalLiabilitiesEquity: | 12252.0000 |
| totalShareholdersEquity: | 6599.0000 | property: | 1091.0000 |
| intangibleAssets: | 3285.0000 | inventories: | 568.0000 |
| accountsReceivable: | 671.0000 | accountsPayable: | 293.0000 |
| liabilitiesTotal: | 5653.0000 | longTermDebt: | 1487.0000 |
| shortTermDebt: | 748.0000 | commonStock: | 2.0000 |
| preferredStock: | 0.0000 | sales: | 4584.0000 |
| depreciation: | 173.0000 | netIncome: | -4404.0000 |
| operatingResult: | -4179.0000 | incomeInterest: | 15.0000 |
| investments: | 1321.0000 | incomeTaxes: | 68.0000 |
| costGoodsSold: | 1612.0000 | grossProfit: | 2972.0000 |
| cashFlow: | 392.0000 | cashFlowInvesting: | -591.0000 |
| cashFlowFinancing: | 1000.0000 | cashFlowTotal: | 779.0000 |
| accountingStandard: | US GAAP | equityRatio: | 53.8606 |
| debtEquityRatio: | 0.3387 | liquidityI: | 0.7252 |
| liquidityII: | 0.9672 | netMargin: | -96.0733 |
| grossMargin: | 64.8342 | cashFlowMargin: | 8.5515 |
| ebitMargin: | -91.1649 | ebitdaMargin: | 0.0000 |
| preTaxROE: | -65.7069 | preTaxROA: | -35.3901 |
| roe: | -66.7374 | roa: | -35.9452 |
| netIncomeGrowth: | -677.9528 | revenuesGrowth: | 1.2815 |
| taxExpenseRate: | -1.5683 | equityTurnover: | 0.6947 |
| epsBasic: | -28.0000 | epsDiluted: | -28.0000 |
| epsBasicGrowth: | -652.2682 | shareCapital: | 2.0000 |
| incomeBeforeTaxes: | -4336.0000 | priceCashFlowRatio: | 81.4990 |
| bookValuePerShare: | 41.7658 | marketCap: | 31947600000.0000 |
| earningsYield: | -13.8477 | cashFlowPerShare: | 2.4810 |
| priceBookValueRatio: | 4.8413 | netEarningsPerShare: | -27.8734 |
| currency: | USD |
| year: | 2023 | units: | 1000000 |
| balanceSheetTotal: | 10111.0000 | cash: | 1048.0000 |
| currentAssets: | 2609.0000 | fixedAssets: | 7502.0000 |
| liabilities: | 1570.0000 | totalLiabilitiesEquity: | 10111.0000 |
| totalShareholdersEquity: | 5745.0000 | property: | 1007.0000 |
| intangibleAssets: | 2993.0000 | inventories: | 587.0000 |
| accountsReceivable: | 734.0000 | accountsPayable: | 245.0000 |
| liabilitiesTotal: | 4366.0000 | longTermDebt: | 1489.0000 |
| shortTermDebt: | 0.0000 | commonStock: | 2.0000 |
| preferredStock: | 0.0000 | sales: | 4504.0000 |
| depreciation: | 191.0000 | netIncome: | -1161.0000 |
| operatingResult: | -1069.0000 | incomeInterest: | 19.0000 |
| investments: | 1354.0000 | incomeTaxes: | 44.0000 |
| costGoodsSold: | 1760.0000 | grossProfit: | 2744.0000 |
| cashFlow: | 478.0000 | cashFlowInvesting: | -231.0000 |
| cashFlowFinancing: | -1210.0000 | cashFlowTotal: | -963.0000 |
| accountingStandard: | US GAAP | equityRatio: | 56.8193 |
| debtEquityRatio: | 0.2592 | liquidityI: | 0.6675 |
| liquidityII: | 1.1350 | netMargin: | -25.7771 |
| grossMargin: | 60.9236 | cashFlowMargin: | 10.6128 |
| ebitMargin: | -23.7345 | ebitdaMargin: | 0.0000 |
| preTaxROE: | -19.4430 | preTaxROA: | -11.0474 |
| roe: | -20.2089 | roa: | -11.4825 |
| netIncomeGrowth: | -73.6376 | revenuesGrowth: | -1.7452 |
| taxExpenseRate: | -3.9391 | equityTurnover: | 0.7840 |
| epsBasic: | -7.3400 | epsDiluted: | -7.3400 |
| epsBasicGrowth: | -73.7857 | shareCapital: | 2.0000 |
| incomeBeforeTaxes: | -1117.0000 | priceCashFlowRatio: | 46.2871 |
| bookValuePerShare: | 36.1548 | marketCap: | 22125236000.0000 |
| earningsYield: | -5.2715 | cashFlowPerShare: | 3.0082 |
| priceBookValueRatio: | 3.8512 | netEarningsPerShare: | -7.3065 |
| currency: | USD |
| year: | 2024 | priceCashFlowRatio: | 47.9193 |
| bookValuePerShare: | 36.1548 | marketCap: | 22862190000.0000 |
| earningsYield: | -5.0919 | pegRatio: | 0.2662 |
| cashFlowPerShare: | 3.0082 | netAssetsPerShare: | 36.1548 |
| priceBookValueRatio: | 3.9870 | netEarningsPerShare: | -7.3065 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2022 |
| units: | 1000000 |
| balanceSheetTotal: | 12252.0000 |
| cash: | 2011.0000 |
| currentAssets: | 3561.0000 |
| fixedAssets: | 8691.0000 |
| liabilities: | 2773.0000 |
| totalLiabilitiesEquity: | 12252.0000 |
| totalShareholdersEquity: | 6599.0000 |
| property: | 1091.0000 |
| intangibleAssets: | 3285.0000 |
| inventories: | 568.0000 |
| accountsReceivable: | 671.0000 |
| accountsPayable: | 293.0000 |
| liabilitiesTotal: | 5653.0000 |
| longTermDebt: | 1487.0000 |
| shortTermDebt: | 748.0000 |
| commonStock: | 2.0000 |
| preferredStock: | 0.0000 |
| sales: | 4584.0000 |
| depreciation: | 173.0000 |
| netIncome: | -4404.0000 |
| operatingResult: | -4179.0000 |
| incomeInterest: | 15.0000 |
| investments: | 1321.0000 |
| incomeTaxes: | 68.0000 |
| costGoodsSold: | 1612.0000 |
| grossProfit: | 2972.0000 |
| cashFlow: | 392.0000 |
| cashFlowInvesting: | -591.0000 |
| cashFlowFinancing: | 1000.0000 |
| cashFlowTotal: | 779.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 53.8606 |
| debtEquityRatio: | 0.3387 |
| liquidityI: | 0.7252 |
| liquidityII: | 0.9672 |
| netMargin: | -96.0733 |
| grossMargin: | 64.8342 |
| cashFlowMargin: | 8.5515 |
| ebitMargin: | -91.1649 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | -65.7069 |
| preTaxROA: | -35.3901 |
| roe: | -66.7374 |
| roa: | -35.9452 |
| netIncomeGrowth: | -677.9528 |
| revenuesGrowth: | 1.2815 |
| taxExpenseRate: | -1.5683 |
| equityTurnover: | 0.6947 |
| epsBasic: | -28.0000 |
| epsDiluted: | -28.0000 |
| epsBasicGrowth: | -652.2682 |
| shareCapital: | 2.0000 |
| incomeBeforeTaxes: | -4336.0000 |
| priceCashFlowRatio: | 81.4990 |
| bookValuePerShare: | 41.7658 |
| marketCap: | 31947600000.0000 |
| earningsYield: | -13.8477 |
| cashFlowPerShare: | 2.4810 |
| priceBookValueRatio: | 4.8413 |
| netEarningsPerShare: | -27.8734 |
| currency: | USD |
| year: | 2023 |
| units: | 1000000 |
| balanceSheetTotal: | 10111.0000 |
| cash: | 1048.0000 |
| currentAssets: | 2609.0000 |
| fixedAssets: | 7502.0000 |
| liabilities: | 1570.0000 |
| totalLiabilitiesEquity: | 10111.0000 |
| totalShareholdersEquity: | 5745.0000 |
| property: | 1007.0000 |
| intangibleAssets: | 2993.0000 |
| inventories: | 587.0000 |
| accountsReceivable: | 734.0000 |
| accountsPayable: | 245.0000 |
| liabilitiesTotal: | 4366.0000 |
| longTermDebt: | 1489.0000 |
| shortTermDebt: | 0.0000 |
| commonStock: | 2.0000 |
| preferredStock: | 0.0000 |
| sales: | 4504.0000 |
| depreciation: | 191.0000 |
| netIncome: | -1161.0000 |
| operatingResult: | -1069.0000 |
| incomeInterest: | 19.0000 |
| investments: | 1354.0000 |
| incomeTaxes: | 44.0000 |
| costGoodsSold: | 1760.0000 |
| grossProfit: | 2744.0000 |
| cashFlow: | 478.0000 |
| cashFlowInvesting: | -231.0000 |
| cashFlowFinancing: | -1210.0000 |
| cashFlowTotal: | -963.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 56.8193 |
| debtEquityRatio: | 0.2592 |
| liquidityI: | 0.6675 |
| liquidityII: | 1.1350 |
| netMargin: | -25.7771 |
| grossMargin: | 60.9236 |
| cashFlowMargin: | 10.6128 |
| ebitMargin: | -23.7345 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | -19.4430 |
| preTaxROA: | -11.0474 |
| roe: | -20.2089 |
| roa: | -11.4825 |
| netIncomeGrowth: | -73.6376 |
| revenuesGrowth: | -1.7452 |
| taxExpenseRate: | -3.9391 |
| equityTurnover: | 0.7840 |
| epsBasic: | -7.3400 |
| epsDiluted: | -7.3400 |
| epsBasicGrowth: | -73.7857 |
| shareCapital: | 2.0000 |
| incomeBeforeTaxes: | -1117.0000 |
| priceCashFlowRatio: | 46.2871 |
| bookValuePerShare: | 36.1548 |
| marketCap: | 22125236000.0000 |
| earningsYield: | -5.2715 |
| cashFlowPerShare: | 3.0082 |
| priceBookValueRatio: | 3.8512 |
| netEarningsPerShare: | -7.3065 |
| currency: | USD |
| year: | 2024 |
| priceCashFlowRatio: | 47.9193 |
| bookValuePerShare: | 36.1548 |
| marketCap: | 22862190000.0000 |
| earningsYield: | -5.0919 |
| pegRatio: | 0.2662 |
| cashFlowPerShare: | 3.0082 |
| netAssetsPerShare: | 36.1548 |
| priceBookValueRatio: | 3.9870 |
| netEarningsPerShare: | -7.3065 |
| currency: | USD |
